The lectin pathway of complement activation

Research in Immunology

Volumn 147, Issue 2, 1996, Pages 110-115

  Turner, M W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT RECEPTOR; LECTIN; MANNOSE;

CANDIDA ALBICANS; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; INFECTION; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; YEAST;

EID: 0029938895     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2494(96)87184-7     Document Type: Article

References (33)

1. Ante-antibody immunity
2. Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans
3. Human mannose-binding protein functions as an opsonin for influenza A viruses
4. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins
5. A new complement-dependent bactericidal factor found in nonimmune mouse sera: specific binding to polysaccharide of Ra chemotype Salmonella
6. Physicochemical properties of a new bactericidal factor, Ra-reactive factor
7. Serum lectin with known structure activates complement through the classical pathway
8. The C4 and C2 but not C1 components of complement are responsible for the complement activation triggered by the Ra-reactive factor
9. The human mannose-binding protein functions as an opsonin
10. Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin
11. Identical point mutation leading to low levels of mannose binding protein and poor C3b mediated opsonization in Chinese and Caucasian populations
12. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene
13. Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q
14. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
15. Human leukocyte C1q receptor binds other soluble proteins with collagen domains
16. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease
17. Human mannose-binding protein is identical to a component of Ra-reactive factor
18. A familial plasma associated defect of phagocytosis a new cause of recurrent bacterial infections
19. The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein
20. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency
21. Defective opsonization: a common immunity deficiency
22. A defect in the alternative pathway of complement
23. Molecular basis of opsonic defect in immunodeficient children
24. Association of low levels of mannan-binding protein with a common defect of opsonisation
25. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations
26. Distinct and overlapping functions of allelic forms of human mannose binding protein
27. A new member of the C1s family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum
28. A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s
29. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response
30. A study of C3b deposition on yeast surfaces by sera of known opsonic potential
31. Supoptimal C3b/C3bi deposition and defective yeast opsonization. — I. Evidence for the absence of essential co-factor activity
32. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential
33. Molecular basis of a common opsonic defect